Compare RC & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RC | CYRX |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | United States |
| Employees | 442 | 1100 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 257.3M | 419.3M |
| IPO Year | N/A | 2008 |
| Metric | RC | CYRX |
|---|---|---|
| Price | $1.69 | $10.12 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | $2.81 | ★ $12.94 |
| AVG Volume (30 Days) | ★ 1.7M | 404.5K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.47% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | $67.36 | $8.45 |
| P/E Ratio | ★ N/A | $7.11 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.50 | $5.21 |
| 52 Week High | $4.75 | $11.45 |
| Indicator | RC | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 52.69 | 71.97 |
| Support Level | $1.65 | $9.18 |
| Resistance Level | $2.15 | $10.23 |
| Average True Range (ATR) | 0.08 | 0.42 |
| MACD | 0.02 | 0.19 |
| Stochastic Oscillator | 87.50 | 92.53 |
Ready Capital Corp is a real estate finance company that originates, acquires, finances, and services LMM loans, SBA loans, construction loans, USDA loans and, to a lesser extent, MBS collateralized mainly by LMM loans or other real estate-related investments. Its loans are used by businesses to purchase real estate used in their operations or by investors seeking to acquire multi-family, office, retail, mixed use or warehouse properties. It operates through two segments: LMM Commercial Real Estate, which originates LMM loans across the life-cycle of an LMM property including construction, bridge, stabilized and agency loan channels, and Small Business Lending, which acquires, originates and services owner-occupied loans guaranteed by the SBA and also originates and services USDA loans.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.